Ziegler Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Ziegler Capital Management's GILD Position: Q1 2024 in Review
Ziegler Capital Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 23,411 shares — an estimated $1.91M sold.
Ziegler Capital Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $13.6M in Q1 2020. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Ziegler Capital Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Ziegler Capital Management sold 23,411 Gilead Sciences shares in Q1 2024, an estimated $1.91M.
- Ziegler Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
- Ziegler Capital Management's Gilead Sciences position peaked at $13.6M in Q1 2020.
- 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.